Clinical Trials

NCT04216472 | TERMINATED | PHASE2
6 participants

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-07
Start Date:
2020-07-10
Completion:
2025-09-22
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Refractory Breast Carcinoma
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
NCT04127214 | COMPLETED
800 participants

The ITA Model of Integrated Treatment of Eating Disorders

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-07
Start Date:
2017-11-02
Completion:
2025-10-31
Conditions
  • Eating Disorders
  • Anorexia Nervosa
  • Bulimia Nervosa
  • Binge Eating
  • Eating Disorders in Adolescence
  • Eating and Feeding Disorders
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page